Details
Category: Volume 06 Issue 04 April 2018
Hits: 1077

Title: To study the Effect of Duration of Smoking on Lipid Parameters in Otherwise Healthy Subjects

Authors: Dr Anvesh Singh Parmar, Dr Deepankar Lahariya

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i4.165

Abstract

Background: India is one of the largest consumers of tobacco worldwide. Addiction of tobacco smoking is related with many health hazards. Nicotine of tobacco can be attributed to changes in lipid profile and its atherogenic complications.

Aims and Objectives: To study and compare lipid levels with severity and duration of smoking in healthy subjects.

Materials and Methods:  Fifty current regular smoker subjects were studied in JA Group of Hospitals and GR Medical College, Gwalior from June 2014 to October 2015.Depending on severity of smoking subjects were classified as mild smokers (regularly between 1-10 cigarettes or bidis/day), moderate smokers (regularly between 11-20 cigarettes or bidis/day and heavy smokers (regularly > 20 cigarettes or bidis/day. Depending on duration of smoking subjects were classified as those between 1-10 years of duration, between 11-20 years of duration and >20 years of smoking duration. All the subjects underwent estimation of total cholesterol (TC), triglycerides (TG), low density lipoproteins (LDL), high density lipoproteins (HDL) and HDL / TC ratio.

Results: Mean TC in smoker and non smoker was 202.2± 26.7 vs 162.2± 22.2 (p < 0.001), mean TG was 195.2±46.3 vs. 145.1±24.1 (p<0.001), mean LDL was128.0 ±28.3 vs. 92.5±20.9 (p<0.001) and mean HDL was34.2±5 vs. 42.2±4.6 (p<0.001) mg/dl respectively. TC (235.7±0.56 vs. 209.6±22.6 vs. 178.9±20.0 respectively), TG (198.6±4.4 vs. 197.1±48.8 vs. 191.3±34.9 respectively) and LDL (170.7±7.7 vs. 136.7±24.3 vs. 107.3±22.9 respectively) were higher in heavy smokers compared to moderate and mild smokers, whereas HDL (32.3±.21 vs. 33.4±4.4 vs. 39.9±6.2 respectively) was lower in heavy smokers compared to moderate and mild smokers.

Conclusion: A direct relationship exists between severity and duration of smoking with an increase in Total Cholesterol, Triglycerides and Low Density Lipoproteins.

Keywords: Smoking severity, duration of smoking, lipid abnormality, CHD.

References

  1. Joshi N, Shah C, Mehta HB, Gokhle PA. Comparative study of lipid profile on healthy smoker and non smokers. Int J Med Sci Public Health 2013; 2:622-626.
  2. Rastogi R, Shrivastava SS, Mehrotra TN, Singh VS, Gupta MK. Lipid profile in smokers. J Assoc Physicians India. 1989;37(12):764-6.
  3. Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest. 1993;23(10):630-40.
  4. Muscat JE, Harris RE et al. Cigarette smoking and plasma cholesterol. Am Heart J 1991; 121: 141-7.
  5. Neki NS. lipid profile in chronic smokers. JIACM. 2002;3:51–54.
  6. Brischetto CS, Connor WE et al. Plasma lipid and lipoprotein profile of cigarette smokers from randomly selected families. Enhancement of hyperlipidaemia and depression of HDL. Am J Cardiol 1983; 52: 675.
  7. Sonaliya K N. The Economics of Tobacco In India. National Journal of Medical Research. 2012; 2(3): 243-244. [2]
  8. Gupta PC, Ray CS. Tobacco, education & health. Indian J Med Res. 2007; 126: 289-299.
  9. Glantz S, Gonzalez M. Effective tobacco control is key to rapid progress in reduction of non-communicable diseases. Lancet. 2012;379(9822):1269-1271.
  10. Chatterjee T, Haldar D, Mallik S, Sarkar GN, Das S, Lahiri SK. A study on habits of tobacco use among medical and non-medical students of Kolkata. Lung India : Official Organ of Indian Chest Society. 2011;28(1):5-10.
  11. Stedmen RL. Chemical composition of tobacco and tobacco smoke. Chem. Rev. 1968; 68(2): 153–207.
  12. Tweed JO, Hsia SH, Lutfy K, Friedman TC. The endocrine effects of nicotine and cigarette smoke. Trends in Endocrinology and Metabolism. 2012;23(7):334-342.
  13. Mizobe F, Livett BG. Nicotine stimulates secretion of both catecholamines and acetylcholinesterase from cultured adrenal chromaffin cells. J Neurosci. 1983 Apr;3(4):871-6.
  14. Arnaldi G, Scandali VM, Trementino L, Cardinaletti M, Appolloni G, Boscaro M. Pathophysiology of dyslipidemia in Cushing's syndrome. Neuroendocrinology. 2010;92Suppl 1:86-90.
  15. Nelson RH. Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Primary care. 2013;40(1):195-211.

Corresponding Author

Dr Deepankar Lahariya

Department of Medicine, GR Medical College, Gwalior, MP India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.,7748979179